Gothenburg School of Business, Economics and Law

Masimo Announces New Member of the Board of Directors

Retrieved on: 
Tuesday, November 7, 2023
Medical Devices, Health, Technology, Health Technology, Cardiology, Auxilium, Pharmacia, Mayo Collaborative Services v. Prometheus Laboratories, Inc., BICO Group, Catalent, Chemical engineering, MASI, Chemical substance, Vice, Business, Perrigo, Central Executive Committee of the Pakistan Peoples Party, Merck Millipore, Supervisory board, Gothenburg University Library, Executive Committee, University of Gothenburg, Gothenburg School of Business, Economics and Law, Retirement, Management, Engineering

Masimo (NASDAQ: MASI) announced today that Rolf A. Classon has been appointed to Masimo’s Board of Directors.

Key Points: 
  • Masimo (NASDAQ: MASI) announced today that Rolf A. Classon has been appointed to Masimo’s Board of Directors.
  • Mr. Classon is an experienced medical technology executive and board member.
  • Mr. Classon was previously Chairman of the Board of Directors of Perrigo Company plc, Chairman of the Board of Directors of Tecan Group Ltd., Chairman of the Board of Directors of Hill-Rom Corporation, and Chairman of the Board of Directors of Auxilium Pharmaceuticals, Inc.
  • Joe Kiani, Chairman and CEO of Masimo, said, “We’re happy to welcome Rolf to our Board.

TRADITIONS BANK WELCOMES JILL E. GILBERT TO ITS BOARD OF DIRECTORS

Retrieved on: 
Thursday, June 22, 2023
OTC Markets Group, PICPA, Chairperson, RKL, Culture, Advisory Committee, Audit committee, Central Penn Business Journal, Dean, Business, Certified Public Accountant, American Institute of Certified Public Accountants, Accounting, Elizabethtown College, AICPA, Friends of Traditional Banking, Partner, School, CPA, CGMA, Growth, New Zealand Women of Influence Awards, Financial management, Woman, American Institute, Central Pennsylvania Institute of Science and Technology, Gothenburg School of Business, Economics and Law, Management

YORK, Pa., June 22, 2023 /PRNewswire/ -- Traditions Bancorp, Inc. (OTC Pink: TRBK), holding company for Traditions Bank, has announced that Jill E. Gilbert joined the bank's Board of Directors at today's board meeting, reflecting the organization's continued progress toward its strategic vision for profitable and responsible growth and expansion.

Key Points: 
  • YORK, Pa., June 22, 2023 /PRNewswire/ -- Traditions Bancorp, Inc. (OTC Pink: TRBK), holding company for Traditions Bank, has announced that Jill E. Gilbert joined the bank's Board of Directors at today's board meeting, reflecting the organization's continued progress toward its strategic vision for profitable and responsible growth and expansion.
  • "Jill Gilbert was an early ally, offering valuable insight as Traditions Bank expanded into Lancaster County," shared Chair of the Board and CEO Eugene Draganosky.
  • Traditions Bank President Thomas Sposito added, "As a charter member of our Lancaster Advisory Board, we witnessed Jill's ability to build relationships.
  • The culture, values, and management style at Traditions Bank align with my own, and I'm excited to join this growing organization."

Infection Control Market worth $58.3 billion | MarketsandMarkets

Retrieved on: 
Thursday, February 9, 2023
Original equipment manufacturer, Hospital, Disinfectant, Clifton Springs Hospital & Clinic, Food industry, University of Gothenburg, Gothenburg School of Business, Economics and Law, Steris, Acquisition, Sterilization, Incidence, Infection, University, Endoscopy, August Faller GmbH & Co. KG, Getinge Group, Economics, Fungal infection, Partnership, Growth, Getinge, School, Houston, Prevalence, Ecolab, Medical device

Based on sterilization products and services, the infection control market is segmented into sterilization equipment, contract sterilization services, and consumables and accessories.

Key Points: 
  • Based on sterilization products and services, the infection control market is segmented into sterilization equipment, contract sterilization services, and consumables and accessories.
  • Based on cleaning and disinfection equipment, the infection control market is segmented into washer disinfector, flusher disinfector, UV-ray disinfector, ultrasonic cleaners, and other cleaning and disinfection equipment.The washer disinfector segment accounted for the largest share of the market during the forecast period.
  • In 2021, the hospitals & clinics segment is expected to register the highest growth in the infection control market.
  • The Asia Pacific infection control market is expected to grow at the highest CAGR during the forecast period of 2022-2027.

Infection Control Market worth $58.3 billion | MarketsandMarkets

Retrieved on: 
Thursday, February 9, 2023
Original equipment manufacturer, Hospital, Disinfectant, Clifton Springs Hospital & Clinic, Food industry, University of Gothenburg, Gothenburg School of Business, Economics and Law, Steris, Acquisition, Sterilization, Incidence, Infection, University, Endoscopy, August Faller GmbH & Co. KG, Getinge Group, Economics, Fungal infection, Partnership, Growth, Getinge, School, Houston, Prevalence, Ecolab, Medical device

Based on sterilization products and services, the infection control market is segmented into sterilization equipment, contract sterilization services, and consumables and accessories.

Key Points: 
  • Based on sterilization products and services, the infection control market is segmented into sterilization equipment, contract sterilization services, and consumables and accessories.
  • Based on cleaning and disinfection equipment, the infection control market is segmented into washer disinfector, flusher disinfector, UV-ray disinfector, ultrasonic cleaners, and other cleaning and disinfection equipment.The washer disinfector segment accounted for the largest share of the market during the forecast period.
  • In 2021, the hospitals & clinics segment is expected to register the highest growth in the infection control market.
  • The Asia Pacific infection control market is expected to grow at the highest CAGR during the forecast period of 2022-2027.

Leading Electronics Manufacturing Partner ACDi Announces Addition of Tom Dykeman as Vice President of Sales

Retrieved on: 
Wednesday, January 18, 2023
Personality, State university system, State University of New York College of Environmental Science and Forestry, Attitude, Growth, ACDI/VOCA, Electronics, Gothenburg School of Business, Economics and Law, Management, MD

FREDERICK, Md., Jan. 18, 2023 /PRNewswire-PRWeb/ -- ACDi, an electronics manufacturing services provider headquartered in Frederick, MD, has appointed Tom Dykeman as Vice President of Sales. In the role of Vice President of Sales, Tom will be responsible for the leadership of the ACDi sales team that includes direct and indirect sales personnel developing new business opportunities that strategically align with the long-term goals of senior management.

Key Points: 
  • FREDERICK, Md., Jan. 18, 2023 /PRNewswire-PRWeb/ -- ACDi, an electronics manufacturing services provider headquartered in Frederick, MD, has appointed Tom Dykeman as Vice President of Sales.
  • In the role of Vice President of Sales, Tom will be responsible for the leadership of the ACDi sales team that includes direct and indirect sales personnel developing new business opportunities that strategically align with the long-term goals of senior management.
  • Tom is a well-known figure in the electronics manufacturing services/contract manufacturing industry with over 35 years of experience.
  • Within the industry, Tom has also held Vice President of Sales positions with Sanmina and most recently with Libra Industries.

Viktoria Ruubel joins Veriff as Managing Director of Digital Identity

Retrieved on: 
Wednesday, January 11, 2023
International Management Institute, New Delhi, Gothenburg School of Business, Economics and Law, Intuit, MIT, Skype, Meta, Digital identity, MBA, CPO, Growth, Tide, SME, University, IPF, Corporate services, Internet, School, University of Gothenburg, University of Tartu, Cryptocurrency, Management, Peeter Ruubel, Veriff, Economics, Science

New York, Jan. 11, 2023 /PRNewswire/ -- Veriff, a global identity verification provider, today announced that Viktoria Ruubel has joined the company as Managing Director of Digital Identity. Ruubel will be responsible for leading the business strategy and expansion of Veriff's core product towards a reusable digital identity platform.

Key Points: 
  • New York, Jan. 11, 2023 /PRNewswire/ -- Veriff , a global identity verification provider, today announced that Viktoria Ruubel has joined the company as Managing Director of Digital Identity.
  • Ruubel will be responsible for leading the business strategy and expansion of Veriff's core product towards a reusable digital identity platform.
  • She joins Veriff from Tide Platform, one of the leading financial platforms in the UK for small businesses.
  • "Reusable digital identity technology is the next generation for identity verification, as it allows individuals and businesses to re-use a single digital identity across different online platforms and applications.

Viktoria Ruubel joins Veriff as Managing Director of Digital Identity

Retrieved on: 
Wednesday, January 11, 2023
International Management Institute, New Delhi, Gothenburg School of Business, Economics and Law, Intuit, MIT, Skype, Meta, Digital identity, MBA, CPO, Growth, Tide, SME, University, IPF, Corporate services, Internet, School, University of Gothenburg, University of Tartu, Cryptocurrency, Management, Peeter Ruubel, Veriff, Economics, Science

New York, Jan. 11, 2023 /PRNewswire/ -- Veriff, a global identity verification provider, today announced that Viktoria Ruubel has joined the company as Managing Director of Digital Identity. Ruubel will be responsible for leading the business strategy and expansion of Veriff's core product towards a reusable digital identity platform.

Key Points: 
  • New York, Jan. 11, 2023 /PRNewswire/ -- Veriff , a global identity verification provider, today announced that Viktoria Ruubel has joined the company as Managing Director of Digital Identity.
  • Ruubel will be responsible for leading the business strategy and expansion of Veriff's core product towards a reusable digital identity platform.
  • She joins Veriff from Tide Platform, one of the leading financial platforms in the UK for small businesses.
  • "Reusable digital identity technology is the next generation for identity verification, as it allows individuals and businesses to re-use a single digital identity across different online platforms and applications.

Anil Srivastava, chief executive officer, leaves Leclanché SA; Board announces management succession and reorganisation

Retrieved on: 
Monday, October 31, 2022
Rhea, SIX Swiss Exchange, Panasonic, JCB, Foglia, SICAV, SA, Leadership, View, Gothenburg School of Business, Economics and Law, Shareholder Meeting, Multimedia, Berkshire Hathaway, EQUITY, Economics, Libera Università Internazionale degli Studi Sociali Guido Carli, MAN, AM, Solution, CEO, Business, Heart, Trust, Blanc, Terminology, Industry, Caterpillar, Chief executive officer, Commercial vehicle, Systems engineering, New Board, Electricity, Volvo, Company, Motor vehicle, Commercial, Engineering, Diagnosis, Fair market value, Cell, Strategic planning, Growth, Phil, CFO, Procter & Gamble, Energizer, Management, Electric battery, Online shopping, Unilab, VARTA, Duracell

Following the appointment of the new board of directors on 30thSeptember 2022, an internal reorganisation of the management was initiated, together with Anil Srivastava, CEO of Leclanch SA.

Key Points: 
  • Following the appointment of the new board of directors on 30thSeptember 2022, an internal reorganisation of the management was initiated, together with Anil Srivastava, CEO of Leclanch SA.
  • As of today, Leclanch group will be managed by Pierre Blanc as Group CEO and by Phil Broad as CEO of Leclanch E-Mobility.
  • They will simultaneously join the executive committee of Leclanch SA with the following roles and functions:
    Phil Broad: CEO of Leclanch e-Mobility SA and chief sales & development officer of Leclanch SA.
  • Philip (Phil) Broad joined Leclanch in 2018 and was appointed executive vice president of e-Mobility Solutions in March 2019.

BioArctic continues to build its commercial organization

Retrieved on: 
Friday, February 18, 2022
MSD, University, CET, Parkinson's disease, Access, Lilly, National, Business administration, National Institute on Aging, Gothenburg School of Business, Economics and Law, AbbVie, Stockholm School of Economics, Person, Senior, Neurodegeneration, Wyeth, Novo Nordisk, Molecular Biotechnology, Partnership, BAN2401, Commercialization, Research, National Institute, Clarity, Roche, Biomarker, Master of Science, Head, AD, Nasdaq, Development, Medical Affairs Bureau, Safety, Bristol Myers Squibb, Janssen, AB, Clinical trial, Eisai, Disease, Karolinska Institute, General manager, Ageing, MBA, Patient, CEO, Doctor of Philosophy, Public affairs, Novartis, US, AstraZeneca, FDA, Pharmaceutical industry, Economics, Nordic, Pfizer, Alzheimer's disease, Uppsala University, Sanofi, Biogen

STOCKHOLM, Feb. 18, 2022 /PRNewswire/ --BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) continues to build the Nordic commercial organization ahead of a potential launch of the company's lead drug candidate, lecanemab, in the Nordic region.

Key Points: 
  • STOCKHOLM, Feb. 18, 2022 /PRNewswire/ --BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) continues to build the Nordic commercial organization ahead of a potential launch of the company's lead drug candidate, lecanemab, in the Nordic region.
  • Under the agreement with Eisai, BioArctic has certain rights to market and sell lecanemab in the Nordic region.
  • In order to prepare for a potential launch, BioArctic has begun the build-up of a Nordic market organization.
  • With the recruitment of these experienced co-workers, we have a good foundation to start this work," says Anna-Kaija Grnblad, Chief Commercial Officer, BioArctic.

BioArctic continues to build its commercial organization

Retrieved on: 
Friday, February 18, 2022
MSD, University, CET, Parkinson's disease, Access, Lilly, National, Business administration, National Institute on Aging, Gothenburg School of Business, Economics and Law, AbbVie, Stockholm School of Economics, Person, Senior, Neurodegeneration, Wyeth, Novo Nordisk, Molecular Biotechnology, Partnership, BAN2401, Commercialization, Research, National Institute, Clarity, Roche, Biomarker, Master of Science, Head, AD, Nasdaq, Development, Medical Affairs Bureau, Safety, Bristol Myers Squibb, Janssen, AB, Clinical trial, Eisai, Disease, Karolinska Institute, General manager, Ageing, MBA, Patient, CEO, Doctor of Philosophy, Public affairs, Novartis, US, AstraZeneca, FDA, Pharmaceutical industry, Economics, Nordic, Pfizer, Alzheimer's disease, Uppsala University, Sanofi, Biogen

STOCKHOLM, Feb. 18, 2022 /PRNewswire/ --BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) continues to build the Nordic commercial organization ahead of a potential launch of the company's lead drug candidate, lecanemab, in the Nordic region.

Key Points: 
  • STOCKHOLM, Feb. 18, 2022 /PRNewswire/ --BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) continues to build the Nordic commercial organization ahead of a potential launch of the company's lead drug candidate, lecanemab, in the Nordic region.
  • Under the agreement with Eisai, BioArctic has certain rights to market and sell lecanemab in the Nordic region.
  • In order to prepare for a potential launch, BioArctic has begun the build-up of a Nordic market organization.
  • With the recruitment of these experienced co-workers, we have a good foundation to start this work," says Anna-Kaija Grnblad, Chief Commercial Officer, BioArctic.